TheraRadar
← Back
Data updated: Mar 29, 2026

PROVENTION BIO INC

MetabolicImmunologyInfectious Disease
Biotech

PROVENTION BIO INC is a biotechnology company focused on Metabolic, Immunology, Infectious Disease.

2022
Since
1
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Metabolic 67%
1 drugs Phase 3: 1
Immunology 20%
0 drugs Phase 2: 1 Phase 1: 1
Infectious Disease 7%
0 drugs Phase 1: 1
Gastroenterology 7%
0 drugs Phase 1: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Infectious Disease, Immunology, Gastroenterology
Merck big-pharma
Infectious Disease, Immunology, Metabolic
Johnson & Johnson big-pharma
Immunology, Infectious Disease, Metabolic
Sanofi big-pharma
Metabolic, Infectious Disease, Immunology
Bristol-Myers Squibb big-pharma
Immunology, Gastroenterology, Infectious Disease